S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.19
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.52
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
CLNN · Clene Inc.
NASDAQ NMS - GLOBAL MARKET - BOATS Real Time Price • USD
$3.78
-0.05
(-1.18%)
● At close: October 21 at 4:00:00 PM EDT
DAY'S RANGE
$3.78
$3.71
$3.81
52-WEEK RANGE
$3.78
$3.02
$13.50
What's happening
- CLNN is down 1.18% today, trading at $3.78. — Live quote
- Volume today (1,038) is well below its 3-month average of 97,750. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-1.08 actual vs. $-0.38 estimated (-187.7%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 2
Buy 8
Hold 1
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (11 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
CLNN
-36.46%
vs S&P 500
-49.23%
1-YEAR RETURN
CLNN
-54.29%
vs S&P 500
-68.85%
6-MONTH RETURN
CLNN
-41.26%
3-MONTH RETURN
CLNN
-36.24%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-1.08
Est. $-0.38
MISS -187.7%
2026-04-26 (Q1 2026)
$-0.27
Est. $-0.65
BEAT +58.4%
2026-01-26 (Q4 2025)
$-0.88
Est. $-0.60
MISS -47.2%
2025-10-26 (Q3 2025)
$-0.85
Est. $-0.59
MISS -43.7%
Valuation Measures & Ratios
Enterprise Value4$62.1M
Forward P/E5—
PEG Ratio6-0.03
Price / Sales (TTM1)269.13
Price / Book712.65
EV4 / Revenue315.08
EV4 / EBITDA—
Profit Margin-20059.90%
Operating Margin-10431.98%
Return on Equity (ROE8)-322.23%
Return on Assets (ROA9)-185.64%
Avg Volume (3M)97,750
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short880,688
Change from Prior Settlement-3.82%
% of Float—
Days to Cover (Short Ratio)7.50
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 233.3% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-10-21; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is -20059.9%. Finnhub fundamentals ↗
- Trailing 52-week price return is -54.3%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on CLNN
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $90.0K | $15.0K | $15.0K | $27.0K | $81.0K | $87.0K | $91.0K | $73.0K |
| Operating income | -$5.3M | -$2.1M | -$5.6M | -$5.9M | -$4.1M | -$7.8M | -$7.4M | -$9.2M |
| Net income | -$13.4M | -$8.1M | -$8.8M | -$7.4M | -$751.0K | -$8.0M | -$6.8M | -$11.1M |
| EPS (diluted) | — | — | — | — | — | — | — | — |
| EPS (basic) | $-1.08 | $-0.69 | $-0.85 | $-0.78 | $-0.09 | $-1.22 | $-1.06 | $-1.73 |
| Operating margin | -$5.9K | -$13.7K | -$37.7K | -$21.7K | -$5.0K | -$9.0K | -$8.1K | -$12.6K |
| Net margin | -$14.9K | -$53.9K | -$58.5K | -$27.5K | -$927 | -$9.2K | -$7.5K | -$15.2K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $23.0M | $21.7M | $18.1M | $22.3M | $22.1M | $25.3M | $27.3M | $31.6M |
| Total liabilities | $47.8M | $40.5M | $35.7M | $34.7M | $30.7M | $30.3M | $36.2M | $35.7M |
| Stockholders' equity | -$24.8M | -$18.8M | -$17.6M | -$12.4M | -$8.6M | -$5.0M | -$8.9M | -$4.1M |
| Total current assets | $14.9M | $13.0M | $9.0M | $12.7M | $12.0M | $14.7M | $16.2M | $19.7M |
| Total current liabilities | $4.9M | $6.7M | $10.8M | $8.3M | $7.6M | $10.8M | $10.3M | $23.8M |
| Cash & equivalents | $9.7M | $5.9M | $5.2M | $7.9M | $7.3M | $9.8M | $12.2M | $14.6M |
| Marketable securities (current) | — | — | — | — | — | — | $0 | $0 |
| Accounts receivable | $43.0K | — | $0 | $0 | $0 | $0 | $64.0K | $0 |
| Inventory | $37.0K | $54.0K | $37.0K | $61.0K | $79.0K | $38.0K | $68.0K | $128.0K |
| Other current assets | $211.0K | $244.0K | $425.0K | $302.0K | $358.0K | $346.0K | $137.0K | $777.0K |
| Property, plant & equipment | — | — | — | — | — | — | — | — |
| Accounts payable | $1.1M | $1.3M | $892.0K | $1.4M | $828.0K | $1.4M | $1.2M | $1.7M |
| Accrued liabilities | $2.5M | $2.7M | $5.0M | $4.9M | $5.4M | $5.2M | $7.8M | $6.7M |
| Deferred revenue (current) | — | — | — | — | — | — | — | — |
| Short-term debt | — | — | — | — | — | — | — | — |
| Long-term debt | $17.6M | $17.7M | $17.8M | $17.9M | $16.5M | $16.6M | — | — |
| Common stock & paid-in capital | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K |
| Retained earnings | -$329.8M | -$316.4M | -$308.3M | -$299.1M | -$290.3M | -$282.9M | -$282.1M | -$268.6M |
| Accumulated other comprehensive income (loss) | $208.0K | $216.0K | $172.0K | $150.0K | $149.0K | $86.0K | $71.0K | $223.0K |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$2.6M | -$4.5M | -$4.8M | -$4.0M | -$4.7M | -$5.0M | -$4.9M | -$3.0M |
| Investing cash flow | -$1.0K | $0 | -$28.0K | -$11.0K | $0 | $0 | -$2.0K | -$1.0K |
| Financing cash flow | $6.3M | $5.2M | $2.1M | $4.6M | $2.1M | $2.7M | $2.5M | -$4.1M |
| Free cash flow | -$2.6M | — | -$4.8M | -$4.0M | -$4.7M | -$5.0M | -$4.9M | -$3.0M |
| Capital expenditures | $1.0K | — | $28.0K | $11.0K | $0 | $0 | $1.0K | $1.0K |
| Share-based compensation | $1.0M | $1.3M | $1.4M | $1.7M | $1.4M | $1.9M | $1.8M | $2.2M |
| Deferred income taxes | — | — | — | — | — | — | — | — |
| Change in accounts receivable | $43.0K | $0 | $0 | $0 | $0 | -$64.0K | $64.0K | $0 |
| Change in inventory | -$17.0K | $17.0K | -$24.0K | -$18.0K | $41.0K | -$30.0K | -$60.0K | $91.0K |
| Change in accounts payable | -$167.0K | $417.0K | -$477.0K | $541.0K | -$585.0K | $173.0K | -$438.0K | $612.0K |
| Purchases of investments | — | — | $0 | $0 | $0 | $0 | $1.0K | $0 |
| Sales/maturities of investments | — | — | $0 | $0 | $0 | $0 | $0 | $0 |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $200.0K | $342.0K | $654.0K | $473.0K | $723.0K |
| Operating income | -$23.1M | -$33.1M | -$40.5M | -$48.4M | -$50.0M |
| Net income | -$26.2M | -$39.4M | -$49.5M | -$29.9M | -$9.7M |
| EPS (basic) | $-2.65 | $-5.67 | $-9.43 | $-0.46 | $-0.16 |
| Operating margin | -$11.5K | -$9.7K | -$6.2K | -$10.2K | -$6.9K |
| Net margin | -$13.1K | -$11.5K | -$7.6K | -$6.3K | -$1.3K |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $18.1M | $27.3M | $52.3M | $44.5M | $63.1M |
| Total liabilities | $35.7M | $36.2M | $39.0M | $41.3M | $50.5M |
| Stockholders' equity | -$17.6M | -$8.9M | $13.4M | $3.2M | $12.6M |
| Total current assets | $9.0M | $16.2M | $38.9M | $29.2M | $54.6M |
| Total current liabilities | $10.8M | $10.3M | $25.3M | $13.9M | $6.0M |
| Cash & equivalents | $5.2M | $12.2M | $28.8M | $18.3M | $50.3M |
| Marketable securities (current) | — | $0 | $6.2M | $5.0M | $0 |
| Accounts receivable | $0 | $64.0K | $143.0K | $189.0K | $49.0K |
| Inventory | $37.0K | $68.0K | $37.0K | $43.0K | $41.0K |
| Other current assets | $139.0K | $137.0K | $568.0K | $581.0K | $404.0K |
| Property, plant & equipment | — | — | — | — | $5.2M |
| Accounts payable | $892.0K | $1.2M | $1.5M | $3.0M | $1.9M |
| Accrued liabilities | $5.0M | $7.8M | $3.7M | $3.9M | $3.6M |
| Deferred revenue (current) | — | — | — | — | $0 |
| Short-term debt | — | — | — | — | — |
| Long-term debt | $17.8M | — | — | — | — |
| Common stock & paid-in capital | $1.0K | $1.0K | $1.0K | $7.0K | $6.0K |
| Retained earnings | -$308.3M | -$282.1M | -$242.7M | -$193.2M | -$163.3M |
| Accumulated other comprehensive income (loss) | $172.0K | $71.0K | $199.0K | $203.0K | $233.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$18.5M | -$21.3M | -$30.2M | -$39.0M | -$34.6M |
| Investing cash flow | -$39.0K | $6.3M | -$1.5M | -$10.2M | -$1.3M |
| Financing cash flow | $11.5M | -$1.5M | $42.2M | $17.2M | $27.1M |
| Free cash flow | -$18.6M | -$21.3M | -$30.5M | -$44.2M | -$36.0M |
| Capital expenditures | $39.0K | $15.0K | $330.0K | $5.2M | $1.3M |
| Share-based compensation | $6.4M | $8.0M | $9.1M | $8.5M | $12.4M |
| Deferred income taxes | — | — | — | $0 | -$282.0K |
| Change in accounts receivable | -$64.0K | -$79.0K | -$46.0K | $140.0K | $28.0K |
| Change in inventory | -$31.0K | $31.0K | -$6.0K | $2.0K | -$150.0K |
| Change in accounts payable | -$348.0K | -$264.0K | -$1.5M | $285.0K | $1.3M |
| Purchases of investments | $0 | $6.2M | $6.2M | $24.6M | $0 |
| Sales/maturities of investments | $0 | $12.5M | $5.0M | $12.0M | $0 |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding CLNN as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Institutional ownership is not available for this symbol right now.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-09-16 to 2026-09-16
Recent transactions
- Most recent: MATLIN DAVID J (Director) — Grant / award of 434,451 shares on 2026-09-16.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)0 sh(0 txns)
Net Shares+0
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| MATLIN DAVID J | Director | Grant / award | 2026-09-16 | 434,451 |
| Etherington Robert Dee | President & CEO | Grant / award | 2026-09-16 | 15,244 |
| Mosca Alison | Director | Grant / award | 2026-09-16 | 198,171 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-16 | MATLIN DAVID J | Director | Grant / award | 434,451 | $3.28 |
| 2026-09-16 | Etherington Robert Dee | President & CEO | Grant / award | 15,244 | $3.28 |
| 2026-09-16 | Mosca Alison | Director | Grant / award | 198,171 | $3.28 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 22:57 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-21 | 4 | 2026-10-20 | View on SEC.gov → |
| 2026-10-21 | 4 | 2026-10-20 | View on SEC.gov → |
| 2026-10-21 | 4 | 2026-10-20 | View on SEC.gov → |
| 2026-10-20 | 8-K | 2026-10-15 | View on SEC.gov → |
| 2026-10-19 | 8-K | 2026-10-19 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-18 | 4 | 2026-09-16 | View on SEC.gov → |
| 2026-09-16 | 8-K | 2026-09-15 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-13 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-13 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-13 | View on SEC.gov → |
Recent news
Headlines about CLNN (Clene Inc.). Links open the publisher — we don’t host full articles.
-
Form 4 Clene Inc.: Robert Dee Etherington (Director, President & CEO) For: 20 October
Investing.com UK · 2026-10-22 -
A 30,000-option grant for Clene (CLNN)'s science chief carries a $3.73 exercise price.
Stock Titan · 2026-10-21 -
12 Health Care Stocks Moving In Tuesday's Intraday Session
Benzinga · 2026-10-20 -
A fourth-year subaward links Clene (CLNN) with New York University on ALS treatment access.
Stock Titan · 2026-10-20 -
Why 3M Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Benzinga · 2026-10-20 -
CLNN Reiterates by HC Wainwright & Co. -- Price Target Maintained at $31
GuruFocus · 2026-10-19 -
Clene Inc. Submits NDA Seeking Accelerated Approval of CNM-Au8 for ALS
Quiver Quantitative · 2026-10-19 -
Clene Announces New Drug Application Submission to FDA for CNM-Au8 for the Treatment of ALS
Yahoo · 2026-10-19
No headlines in this category right now — try “All”.